Species: Lachnoanaerobaculum orale (HMT-0082) Primary Body Site: Oral
Download Options
LINKS: Ecology Home
| HMT-0082: [Body Sites Data]
[Taxon Description]
| Life Page: Lachnoanaerobaculum orale
Hide Legend
Prev - Prevalence
10thp - 10th percentile
90thp - 90th percentile
ND - less than 0.001%
Body Site Legend:
| SUBP-- Subgingival Plaque |
| SUPP -- Supragingival Plaque |
| PERIO -- Periodontal |
| AKE -- Attached Keratinized Gingiva |
| BMU -- Buccal Mucosa |
| HPA -- Hard Palate |
| SAL -- Saliva |
| THR -- Throat |
| PTO -- Palatine Tonsils |
| TDO -- Tongue Dorsum |
| ANA -- Anterior Nares |
| LRC -- L_Retroauricular Crease |
| RRC -- R_Retroauricular Crease |
| LAF -- L_Antecubital Fossa |
| RAF -- R_Antecubital Fossa |
| VIN -- Vaginal Introitus |
| MVA -- Mid Vagina |
| PFO -- Posterior Fornix |
| STO -- Stool |
Prev - Prevalence
10thp - 10th percentile
90thp - 90th percentile
ND - less than 0.001%
Human Microbiome Project Mapping (Data from healthy subjects. - not published)
No Notes
| SUBP | SUPP | PERIO | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | LRC | RRC | RAF | VIN | MVA | PFO | STO | |
| Avg (%) | 0.03 | 0.03 | 0.04 | 0.02 | 0.04 | 0.03 | 0.10 | 0.56 | 0.32 | 0.43 | 0.05 | 0 | 0 | 0.01 | 0 | 0.01 | 0.01 | 0.01 |
| n | 24 | 395 | 24 | 15 | 323 | 1 | 8 | 7 | 22 | 423 | 65 | 23 | 30 | 1 | 4 | 8 | 94 | 375 |
| 10thp | 0 | 0 | 0 | 0 | 0.01 | 0.03 | 0.01 | 0.27 | 0.03 | 0.02 | 0 | 0 | 0 | 0.01 | 0 | 0 | 0 | 0 |
| 90thp | 0.06 | 0.05 | 0.07 | 0.05 | 0.10 | 0.03 | 0.22 | 0.93 | 0.79 | 1.08 | 0.05 | 0 | 0 | 0.01 | 0 | 0.03 | 0.02 | 0.01 |
| Stdev | 0.03 | 0.04 | 0.10 | 0.03 | 0.07 | 0 | 0.10 | 0.34 | 0.34 | 0.49 | 0.26 | 0 | 0 | 0 | 0 | 0.02 | 0.01 | 0.05 |
| Prev(%) | 25.00 | 18.48 | 12.50 | 13.33 | 7.74 | 100.00 | 37.50 | 100.00 | 50.00 | 81.32 | 3.08 | 0 | 0 | 0 | 0 | 0 | 0 | 0.80 |
Eren V1-V3 www.pnas.org
(Data from healthy subjects.)
Notes:
reads equally close to L orale and L. umeanse were assigned half to each taxon
reads equally close to L. orale, L. saburreum, and L. umeanse were assigned one third to each taxon
reads equally close to L orale and L. umeanse were assigned half to each taxon
reads equally close to L. orale, L. saburreum, and L. umeanse were assigned one third to each taxon
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | STO | |
| Avg (%) | 0.10 | 0.09 | 0.01 | 0.08 | 0.15 | 0.13 | 0.49 | 0.38 | 0.36 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0.01 | 0 | 0.04 | 0.05 | 0.07 | 0 |
| 90thp | 0.31 | 0.28 | 0.05 | 0.20 | 0.29 | 0.29 | 0.94 | 0.76 | 0.63 | 0 |
| Stdev | 0.15 | 0.16 | 0.04 | 0.10 | 0.14 | 0.13 | 0.60 | 0.34 | 0.38 | 0.01 |
| Prev(%) | 74.03 | 64.94 | 45.45 | 84.42 | 92.21 | 84.42 | 92.21 | 97.40 | 98.70 | 9.09 |
Eren V3-V5 www.pnas.org
(Data from healthy subjects.)
Notes:
Reads equally close to L. orale and L. umeanse were assigned half to each taxon.
Reads equally close to L. orale and L. umeanse were assigned half to each taxon.
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | STO | |
| Avg (%) | 0.14 | 0.14 | 0.05 | 0.13 | 0.39 | 0.32 | 1.00 | 0.76 | 0.85 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0.04 | 0.07 | 0.12 | 0.09 | 0.11 | 0 |
| 90thp | 0.34 | 0.42 | 0.10 | 0.36 | 0.97 | 0.66 | 2.60 | 1.78 | 2.00 | 0 |
| Stdev | 0.26 | 0.24 | 0.22 | 0.17 | 0.45 | 0.31 | 1.26 | 0.75 | 0.98 | 0 |
| Prev(%) | 70.95 | 68.92 | 40.54 | 84.46 | 95.95 | 96.62 | 98.65 | 97.30 | 98.65 | 0 |
Human Microbiome Project 16S RefSeq (V1-V3) (Data from healthy subjects. - not published)
Notes:
Reads equidistant to HMT-082 and HMT-107 were assigned to each taxon in proportion to the abundance of HMT-082 and HMT-107 individually at this body site (THR).
Reads equidistant to HMT-082 and HMT-107 were assigned to each taxon in proportion to the abundance of HMT-082 and HMT-107 individually at this body site (THR).
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | LRC | RRC | LAF | RAF | VIN | MVA | PFO | STO | |
| Avg (%) | 0.09 | 0.09 | 0.03 | 0.07 | 0.24 | 0.14 | 0.61 | 0.46 | 0.53 | 0 | 0 | 0 | 0.01 | 0.02 | 0 | 0 | 0 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0 | 0.01 | 0.02 | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 0.30 | 0.27 | 0.07 | 0.20 | 0.59 | 0.37 | 1.54 | 1.14 | 1.46 | 0 | 0 | 0 | 0 | 0.02 | 0 | 0 | 0 | 0 |
| Stdev | 0.20 | 0.19 | 0.09 | 0.10 | 0.36 | 0.23 | 0.78 | 0.53 | 0.71 | 0 | 0 | 0 | 0.08 | 0.13 | 0 | 0 | 0 | 0 |
| Prev(%) | 53.64 | 55.63 | 32.17 | 69.86 | 83.89 | 70.00 | 89.88 | 92.00 | 94.19 | 0 | 0 | 0 | 4.60 | 10.60 | 0 | 0 | 0 | 0 |
Human Microbiome Project 16S RefSeq (V3-V5) (Data from healthy subjects. - not published)
Notes:
Reads equidistant to HMT-082 and HMT-494 were assigned to each taxon in proportion to the abundance of HMT-082 and HMT-494 individually at these sites (SUBP,SUPP).
Reads equidistant to HMT-082 and HMT-494 were assigned to each taxon in proportion to the abundance of HMT-082 and HMT-494 individually at these sites (SUBP,SUPP).
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | LRC | RRC | LAF | RAF | VIN | MVA | PFO | STO | |
| Avg (%) | 0.07 | 0.04 | 0.07 | 0.20 | 0.54 | 0.29 | 1.25 | 1.00 | 1.07 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 0.18 | 0.13 | 0.16 | 0.59 | 1.48 | 0.71 | 3.56 | 2.80 | 3.03 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stdev | 0.16 | 0.13 | 0.31 | 0.33 | 0.75 | 0.36 | 1.51 | 1.29 | 1.36 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Prev(%) | 51.36 | 44.39 | 27.65 | 66.75 | 76.22 | 82.44 | 82.87 | 86.38 | 84.67 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Dewhirst 35x9 (35 Taxa by 9 Oral Sites. - not published)
No Notes
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | |
| Avg (%) | 0 | 0.01 | 0.01 | 0.02 | 0.06 | 0.06 | 0.14 | 0.14 | 0.10 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0 | 0.01 | 0 | 0 | 0 |
| 90thp | 0.01 | 0.01 | 0.04 | 0.03 | 0.13 | 0.16 | 0.32 | 0.38 | 0.25 | 0 |
| Stdev | 0.01 | 0.02 | 0.03 | 0.06 | 0.13 | 0.10 | 0.21 | 0.22 | 0.12 | 0 |
| Prev(%) | 41.89 | 67.65 | 58.14 | 77.14 | 85.71 | 78.00 | 100.00 | 87.10 | 90.00 | 0 |
Human Microbiome Project Metaphlan (Data from healthy subjects. - not published)
No Notes
| SUBP | SUPP | PERIO | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | LRC | RRC | RAF | VIN | MVA | PFO | STO | |
| Avg (%) | 0.01 | 0.01 | 0.03 | 0.01 | 0.04 | 0.04 | 0.10 | 0.31 | 0.39 | 0.51 | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0.04 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 0.04 | 0.03 | 0.04 | 0.05 | 0.09 | 0.04 | 0.24 | 0.93 | 1.04 | 1.31 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stdev | 0.03 | 0.04 | 0.09 | 0.03 | 0.11 | 0 | 0.12 | 0.42 | 0.51 | 0.61 | 0.17 | 0 | 0 | 0 | 0.01 | 0 | 0.01 | 0.04 |
| Prev(%) | 33.33 | 24.75 | 25.00 | 23.53 | 26.60 | 100.00 | 62.50 | 56.25 | 64.00 | 82.86 | 0.90 | 0 | 0 | 0 | 9.09 | 0 | 0.51 | 0.91 |

